Retrospective Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Mar 28, 2016; 22(12): 3392-3403
Published online Mar 28, 2016. doi: 10.3748/wjg.v22.i12.3392
Table 1 Donor risk conditions for hypoxic cholangiopathy
ResultRange
Age29.7 ± 10.49-53
Body mass index (kg/m2)25.7 ± 4.118-36
Pre-op pressors = 029/44 (65.9%)
Pre-op pressors = 19/44 (20.5%)
Pre-op pressors ≥ 26/44 (13.6%)
Red blood cell transfusion11/44 (25.03%)
Pre-op hemoglobin (g/dL)11.7 ± 2.34.8-16.5
Pre-op mean arterial pressure (mmHg)88.6 ± 17.857-121
Pre-op SpO2 (%)97.3 ± 5.465-100
Pre-op PaO2 (torr)181.9 ± 114.741-472
Pre-op arterial O2 content (mL/100 mL)16.0 ± 3.37.5-23.2
Donor hypoxia accrual time (min)20.8 ± 5.59.0-33.0
Extubation-to-asystole time (min)12.6 ± 5.24.0-24.0
Asystole-to-aortic clamp time (min)8.2 ± 2.45.0-14.0
Donor ischemia time (min)12.4 ± 6.12-25
Donor hypoxemia time (min)14.2 ± 6.11-29
Donor hypoxia score2.3 ± 1.10.4-4.8
Pre-donation length of stay (d)3.8 ± 2.31-13
No arrest24 (53.3%)
Pre-donor duration of arrest (min)31.5 ± 20.63-75
Table 2 Hypoxic cholangiopathy correlations with preoperative donor oxygen delivery
(-) Hypoxic cholangiopathy(+) Hypoxic cholangiopathyP value
n2222
Age25.6 ± 8.433.0 ± 10.60.020
Multiple pressor administration27.3%0.0%0.009
RBC transfusion36.4%9.5%0.040
RBC or multiple pressor administration54.6%9.5%0.001
Hemoglobin12.3 ± 2.110.7 ± 2.20.020
Arterial O2 content (mL/100 mL)16.8 ± 3.314.8 ± 2.80.049
Mean arterial pressure (mmHg)83.8 ± 18.592.7 ± 16.20.100
Table 3 Comparison of patients with preoperative multiple pressors or red blood cell transfusion
(-) Multiple-pressor/RBC(+) Multiple-pressor/RBCP value
n29 (67.4%)14 (32.6%)
Hypoxic cholangiopathy19 (65.5%)2 (14.3%)0.001
Initial pH7.33 ± 0.147.25 ± 0.120.08
Pre-op pH7.43 ± 0.067.39 ± 0.080.07
Initial PaO2156.4 ± 84.0133.6 ± 117.60.48
Pre-op PaO2171.5 ± 106.1191.2 ± 129.80.60
Initial SpO2 (%)97.5 ± 2.792.2 ± 9.90.012
Pre-op SpO2 (%)97.9 ± 2.095.9 ± 8.80.41
Initial P/F O2228.5 ± 116191.4 ± 930.40
Pre-op P/F O2212.5 ± 101243.8 ± 1260.41
Initial PEEP (cmH2O)6.0 ± 2.75.6 ± 3.90.69
Pre-op PEEP (cmH2O)7.1 ± 4.67.0 ± 4.50.96
Pre-op hemoglobin (g/dL)11.8 ± 1.911.8 ± 2.50.99
Arterial O2 content (mL/100 mL)16.2 ± 2.516.1 ± 4.00.93
Pre-op systolic pressure (mmHg)133.6 ± 21.9123.5 ± 26.80.19
Pre-op diastolic pressure (mmHg)74.3 ± 15.764.3 ± 18.10.06
Pre-op mean pressure (mmHg)92.1 ± 16.682.1 ± 19.20.08
Pre-op heart rate (bpm)92.3 ± 20.296.9 ± 22.30.49
Table 4 Hypoxic cholangiopathy correlations with donor post-extubation hypoxia
(-) Hypoxic cholangiopathy(+) Hypoxic cholangiopathyP value
n2222
Donor hypoxia accrual time (min)20.3 ± 5.821.6 ± 5.20.470
Extubation-to-asystole time (min)12.0 ± 5.113.4 ± 5.40.380
Asystole-to-aortic clamp time (min)8.3 ± 2.68.1 ± 2.30.800
Donor ischemia time (min)11.7 ± 7.413.5 ± 4.20.340
Donor hypoxemia time (min)13.2 ± 6.515.5 ± 5.60.220
Preoperative hemoglobin (g/dL)12.3 ± 2.110.7 ± 2.20.017
Donor hypoxia score2.0 ± 1.22.7 ± 0.90.030
Donor hypoxia score > 2.025.0%69.6%0.006
Table 5 Recipient risk variables - n = 45 n (%)
ResultRange
Hepatitis-C13 (28.9)
Ethanol6 (13.3)
Alpha-1 antitrypsin9 (20.0)
Hepatitis B3 (6.7)
Hepatocellular carcinoma18 (40.0)
≥ 2 diagnoses21 (46.7)
MELD28.7 ± 5.617-40
Duct to duct anastamosis38 (84.4)
Cold-ischemia time (min)429.9 ± 127.360-660
Warm-ischemia time (min)35.4 ± 13.616-76
Total-ischemia time (min)465.6 ± 131.095-688
Table 6 Era 1 and era 2 risk comparisons
Era 1Era 2P value
DCD liver transplants1727
Hypoxic cholangiopathy29.4%63.0%0.030
Transplants per year2.57.10.100
Hepatocellular carcinoma23.5%51.9%0.060
Donor body mass index (kg/m2)24.1 ± 3.126.7 ± 4.30.030
Donor hypoxia accrual time (min)17.3 ± 5.022.7 ± 4.80.001
Donor extubation-to-asystole time (min)9.3 ± 4.514.4 ± 4.70.001
Donor aystole-to-crossclamp time (min)8.1 ± 2.78.3 ± 2.30.779
Donor ischemia time (min)9.7 ± 5.613.9 ± 5.90.030
Donor hypoxemia time (min)11.1 ± 6.716.0 ± 5.10.013
Donor hypoxia score1.6 ± 0.92.7 ± 1.10.003
Donor hypoxia score > 2.028.6%73.1%0.006
Recipient cold ischemia time (min)381 ± 139461 ± 1110.040
Recipient warm ischemia time (min)31 ± 1039 ± 150.030
Recipient total ischemia time (min)411.8 ± 135499.4 ± 1190.030